Attached files

file filename
EX-10.11 - EXHIBIT 10.11 - Elevation Oncology, Inc.tm2111147d20_ex10-11.htm
S-1/A - S-1/A - Elevation Oncology, Inc.tm2111147-19_s1a.htm


Exhibit 23.1




We consent to the inclusion in this Amendment No. 3 to the Registration Statement on Form S-1 of Elevation Oncology, Inc. of our report dated April 9, 2021, except for the effects of the matters discussed in Note 13, which is as of June 17, 2021, and which includes an explanatory paragraph related to Elevation Oncology, Inc’s ability to continue as a going concern, on our audits of the financial statements of Elevation Oncology, Inc. as of December 31, 2019 and 2020 and for the period from April 29, 2019 (Inception) through December 31, 2019, and the year ended December 31, 2020. We also consent to the reference to our firm under the heading “Experts.”


/s/ CohnReznick LLP


Tysons, Virginia

June 21, 2021